StonvexLoading…
StonvexStonvexStonvexCore line items from CRUS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-03-29 | Annual 2024 2024-03-30 | Annual 2023 2023-03-25 | Annual 2022 2022-03-26 |
|---|---|---|---|---|
Revenue | $1.90B | $1.79B | $1.90B | $1.78B |
Operating Income | $410.36M | $343.47M | $249.03M | $366.34M |
Net Income | $331.51M | $274.57M | $176.70M | $326.36M |
EPS (Diluted) | $6.00 | $4.90 | $3.09 | $5.52 |
Total Assets | $2.33B | $2.23B | $2.06B | $2.12B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $539.62M | $502.76M | $445.78M | $369.81M |
Free Cash Flow OCF − CapEx | $421.59M | $384.02M | $304.48M | $98.61M |
Shares Outstanding | 52.29M | 53.49M | 55.10M | 56.60M |